Camille Bigenwald

9PUBLICATIONS
73CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 24, 2026
Addendum: RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.

|Sep 24, 2025
CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Myriam Ben Khelil, Ahmadreza Arbab, Janesa Srikanthan

|Jun 11, 2025
Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Laura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil

|Aug 25, 2023
BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

Liwei Zhao, Peng Liu, Misha Mao

|Oct 08, 2021
Histiocytic disorders.

Kenneth L McClain, Camille Bigenwald, Matthew Collin

|May 07, 2021
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology.

Camille Bigenwald, Jessica Le Berichel, C Matthias Wilk

Pageof 2

Frequent Collaborators

4 joint publications

Miriam Merad

3 joint publications

Jessica Rengassamy

3 joint publications

Howard Lin

3 joint publications

Janesa Srikanthan